Vitamin status and psychiatric disorders

Lifetime Nutritional Influences on Cognition, Behaviour and Psychiatric Illness

Volumn , Issue , 2011, Pages 359-391

  Benton, David ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; Anti oxidants; Autism; Dementia; Depression; Folate; Homocysteine; Niacin; Oxidative stress; Schizophrenia; Vitamin B12; Vitamin B6

Indexed keywords

EID: 84902403598     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9780857092922.3.359     Document Type: Chapter

References (127)

1. Aisen P.S., Schneider L.S., Sano M., Diaz-Arrastia R., Van Dyck C.H., Weiner M.F., Bottiglieri T., Jin S., Stokes K.T., Thomas R.G., Thal L.J. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. J Am Med Assoc 2008, 300:1774-1783.
2. Almeida O.P., Flicker L., Lautenschlager N.T., Leedman P., Vasikaran S., Van Bockxmeer F.M. Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life. Neurobiol Aging 2005, 26:251-257.
3. Almeida O.P., Flicker L., Norman P., Hankey G.J., Vasikaran S., Van Bockxmeer F.M., Jamrozik K. Association of cardiovascular risk factors and disease with depression in later life. Am J Geriatr Psychiatry 2007, 15:506-513.
4. Almeida O.P., Mccaul K., Hankey G.J., Norman P., Jamrozik K., Flicker L. Homocysteine and depression in later life. Arch Gen Psychiatry 2008, 65:1286-1294.
5. Balk E.M., Raman G., Tatsioni A., Chung M., Lau J., Rosenberg I.H. Vitamin B6, B12, and folic acid supplementation and cognitive function. A systematic review of randomized trials. Arch Intern Med 2007, 167:21-30.
6. Benton D. Neuro-development and neuro-degeneration. Are there critical stages for nutritional intervention? Nutr Rev 2010, 68(Suppl):S6-S10.
7. Benton D., Haller J., Fordy J. Vitamin supplementation for 1year improves mood. Neuropsychobiol 1995, 32:98-105.
8. Benton D., Griffiths R., Haller J. Thiamine supplementation mood and cognitive functioning. Psychopharmacol 1997, 129:66-71.
9. Benton D., Kallus K.W., Schmitt J.A.J. How should we measure nutrition- induced improvements in memory?. Eur J Nutr 2005, 44:485-498.
10. 12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry 2003, 60:618-626.
11. Bliss J.P., Gibson G.E. Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndrome. New Eng J Med 1977, 297:1367-1370.
12. Brozek J. Psychological effects of thiamine restriction and deprivation in normal young men. Am J Clin Nutr 1957, 5:109-118.
13. Bryan J., Calvaresi E., Hughes D. Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. J Nutr 2002, 132:1345-1356.
14. Chen C.S., Tsai J.C., Tsang H.Y., Kuo Y.T., Lin H.F., Chiang I.C., Devanand D.P. Homocysteine levels, MTHFR C677T genotype, and MRI Hyperintensities in late-onset major depressive disorder. Am J Geriatr Psychiatry 2005, 13:869-875.
15. Cohen M., Bendich A. Safety of pyridoxine - a review of human and animal studies. Toxicol Lett 1986, 34:129-139.
16. Coppen A., Bailey J. Enhancement of the antidepressant fluoxetine by folic acid: a randomised placebo controlled trial. J Affect Disord 2000, 60:121-123.
17. Coppen A., Bolander-Gouaille C. Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol 2005, 19:59-65.
18. Clarke R. B-vitamins and prevention of dementia. Proc Nutr Soc 2008, 67:75-81.
19. Connelly P.J., Prentice N.P., Cousland G., Bonham J. A randomised doubleblind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease. Int J Geriatr Psychiatry 2008, 23:155-160.
20. Dangour A.D., Sibson V.L., Fletcher A.E. Hormones and supplements: do they work? Micronutrient supplementation in later life: limited evidence for benefit. J Gerontol A Biol Sci Med Sci 2004, 59:B659-B673.
21. Day E., Bentham P., Callagham R., Kuruvilla T., George S. Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse. Cochrane Database Syst Rev 2004, CD004033.
22. De Wardener H.E., Lennox B. Cerebral Beriberi (Wernicke's Encephalopa- thy). Lancet 1947, I:11-17.
23. Deijen J.B., Van Der Beek E.J., Orlebeke J.F., Van Den Berg H. Vitamin B-6 supplementation in elderly men: effects on mood, memory, performance and mental effort. Psychopharmacol 1992, 109:489-496.
24. Delgado-Sanchez L., Godkar D., Niranjan S. Pellagra: rekindling of an old flame. Am J Ther 2008, 15:173-175.
25. Dickerson J.W.T., Wiryanti J. Pellagra and mental disturbance. Proc Nutr Soc 1978, 37:167-171.
26. 1998, Dietary Reference Intakes, National Academy Press, Washington DC.
27. Durga J., Van Boxtel M.P., Schouten E.G., Kok F.J., Jolles J., Katan M.B., Verhoef P. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007, 369(9557):208-216.
28. Korsakoff's syndrome. Lancet 1990, 336:912-913. Editorial.
29. Engelhart M.J., Geerlings M.I., Ruitenberg A., Van Swieten J.C., Hofman A., Witteman J.C., Breteler M.M. Dietary intake of antioxidants and risk of Alzheimer disease. J Am Med Assoc 2002, 287:3223-3229.
30. 12 with or without folic acid on cognitive function in older people with mild vitamin deficiency a randomized placebo controlled trial. Am J Clin Nutr 2006, 84:361-370.
31. Fillenbaum G.G., Kuchibhatla M.N., Hanlon J.T., Artz M.B., Pieper C.F., Schmader K.E., Dysken M.W., Gray S.L. Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E. Ann Pharmacother 2005, 39:2009-2014.
32. Fioravanti M., Ferrario E., Massaia M., Cape G., Rivolta G., Grossi E., Buckley A.E. Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits. Arch Gerontol Geriatr 1998, 26:1-13.
33. Folstein M., Liu T., Peter I., Buel J., Arsenault L., Scott T., Qiu W.W. The homocysteine hypothesis of depression. Am J Psychiatry 2007, 164:861-867.
34. Ford A.H., Flicker L., Thomas J., Norman P., Jamrozik K., Almeida O.P. Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial. J Clin Psychiatry 2008, 69:1203-1209.
35. 12 et etat dementiel etude epidemiologique multicentrique et therapeutique essai preliminaire]. Semaine Des Hopitaux 1997, 73:133-140.
36. Gaysina D., Cohen S., Craddock N., Farmer A., Hoda F., Korszun A., Owen M.J., Craig I.W., Mcguffin P. No association with the 5,10-methylenetetrahydrofolate reductase gene and major depressive disorder: results of the depression case control (DeCC) study and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:699-706.
37. Godfrey P.S., Toone B.K., Carney M.W., Flynn T.G., Bottiglieri T., Laundy M., Chanarin I., Reynolds E.H. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990, 336:392-395.
38. Gray S.L., Anderson M.L., Crane P.K., Breitner J.C., Mccormick W., Bowen J.D., Teri L., Larson E. Antioxidant vitamin supplement use and risk of dementia or Alzheimer's disease in older adults. J Am Geriatr Soc 2008, 56:291-295.
39. Grodstein F., Chen J., Willett W.C. High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am J Clin Nutr 2003, 77:975-984.
40. Harman D. A theory based on radical and radiation chemistry. J Gerontol 1956, 11:298-300.
41. Harper C. The incidence of Wernicke's encephalopathy in Australia - a neuropathological study of 131 cases. J Neurol Neurosurg Psychiatry 1983, 46:593-598.
42. Harper C. The neuropathology of alcohol-related brain damage. Alcohol Alcohol 2009, 44:136-140.
43. Harrell R.F. Mental responses to added thiamine. J Nutr 1946, 31:283-298.
44. Heeley A.F., Roberts G.E. A study of tryptophan metabolism in psychotic children. Dev Med Child Neurol 1966, 3:708-718.
45. Herbert V. Experimental nutritional folate deficiency in man. Trans Assoc Am Physicians 1962, 75:307-320.
46. Heseker H., Kubler W., Westenhofer J., Pudel V. Psychische Veranderungen als Fruhzeichen einer suboptimalen Vitaminversorgung. Ernahrungs-Umschau 1990, 37:87-94.
47. Hoffer A., Osmond H. Treatment of schizophrenia with nicotinic acid. A ten year follow-up. Acta Psychiat Scand 1964, 40:171-189.
48. Hoffer A., Osmond H. Megavitamin Therapy in reply to The American Psychiatric Association Task Force Report on Megavitamin and Orthomolecular Therapy in Psychiatry 1976, Canadian Schizophrenia Foundation, Toronto.
49. Hoffer A., Osmond H., Callbeck M.J., Kahan I. Treatment of schizophrenia with nicotinic acid and nicotinamide. J Clin Exp Psychopathol 1957, 18:131-158.
50. Hommer D., Momenan R., Kaiser E., Rawlings R. Evidence for a gender-related effect of alcoholism on brain volumes. Am J Psychiatry 2001, 158:198-204.
51. Hvas A.M., Juul S., Lauritzen L., Nexo E., Ellegaard J. No effect ofvitamin B12 treatment on cognitive function and depression: a randomized placebo controlled study. J Affective Disord 2004, 81:269-273.
52. Jack C.R., Petersen R.C., Grundman M., Jin S., Gamst A., Ward C.P., Sencakova D., Doody R.S., Thal L.J. Longitudinal MRI findings from the vitamin E and done-zepil treatment study for MCI Members of the Alzheimer's Disease Cooperative Study (ADCS). Neurobiol Aging 2008, 29:1285-1295.
53. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., Selhub J., Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996, 93:7-9.
54. Kang J.H., Cook N., Manson J., Buring J.E., Grodstein F. A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 2006, 166:2462-2468.
55. Kang J.H., Cook N., Manson J., Buring J.E., Albert C.M., Grodstein F. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr 2008, 88:1602-1610.
56. Keys A., Henschel A.F., Mickelson O., Brozek J. The performance of normal young men on controlled thiamine intake. J Nutr 1943, 26:399-415.
57. 6 in mental functioning: a review of controlled trials in humans. Biol Psychiatry 1991, 29:931-941.
58. Kuriyama S., Kamiyama M., Watanabe M., Tamahashi S., Muraguchi I., Watanabe T., Hozawa A., Ohkubo T., Nishino Y., Tsubono Y., Tsuji I., Hisamichi S. Pyri-doxine treatment in a subgroup of children with pervasive developmental disorders. Dev Med Child Neurol 2002, 44:284-286.
59. Laurin D., Masaki K.H., Foley D.J., White L.R., Launer L.J. Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia. Aging Study. Am J Epidemiol 2004, 159:959-967.
60. Lewis S.J., Lawlor D.A., Davey Smith G., Araya R., Timpson N., Day I.N., Ebrahim S. The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis. Mol Psychiatry 2006, 11:352-360.
61. Lipton M. Task Force Report on Megavitamin and Orthomolecular Therapy in Psychiatry 1973, American Psychiatric Association, Washington, DC.
62. Lonsdale D., Shamburger R.J. Red cell transketolase as an indicator of nutritional deficiency. Am J Clin Nutr 1980, 33:205-211.
63. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated thiobar- bituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 1995, 45:1594-1601.
64. Luchsinger J.A., Tang M.X., Shea S., Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003, 60:203-208.
65. Luchsinger J.A., Tang M.X., Shea S., Miller J., Green R., Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004, 62:1972-1976.
66. 12 for cognition. Cochrane Database Syst Rev 2009, CD004326.
67. 6 on cognition. Cochrane Database Syst Rev 2003, CD004393.
68. 12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 2008, CD004514.
69. Markesbery W.R., Carney J.M. Oxidative alterations in Alzheimer's disease. Brain Pathol 1999, 9:133-146.
70. Martin D.C., Francis J., Protetch J., Huff F.J. Time dependency of cognitive recovery with cobalamin replacement: Report of a pilot study. J Amer Geriatr Soc 1992, 40:168-172.
71. Masaki K.H., Losonczy K.G., Izmirlian G., Foley D.J., Ross G.W., Petrovitch H., Havlik R., White L.R. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000, 54:1265-1272.
72. Maxwell C.J., Hicks M.S., Hogan D.B., Basran J., Ebly E.M. Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia. Dement Geriatr Cogn Disord 2005, 20:45-51.
73. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Aggarwal N., Wilson R.S., Scherr P.A. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. J Am Med Assoc 2002, 287:3230-3237.
74. Morris M.C., Evans D.A., Tangney C.C., Bienias J.L., Wilson R.S., Aggarwal N.T., Scherr P.A. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr 2005, 81:508-514.
75. Morris M.S., Jacques P.F., Rosenberg I.H., Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 2007, 85:193-200.
76. Mendelsohn A.B., Belle S.H., Stoehr G.P., Ganguli M. Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES Project. Monongahela Valley Independent Elders Survey. Am J Epidemiol 1998, 148:38-44.
77. Nadel A., Burger P.C. Wernicke Encephalopalopathy following prolonged intravenous therapy. J Am Med Assoc 1976, 235:2403-2405.
78. Nanri A., Mizoue T., Matsushita Y., Sasaki S., Ohta M., Sato M., Mishima N. Serum folate and homocysteine and depressive symptoms among Japanese men and women. Eur J Clin Nutr 2010, 64:289-296.
79. Nilsson L.G. Memory function in normal aging. Acta Neurol Scand 2003, 179:7-13.
80. Ntaios G., Savopoulos C., Grekas D., Hatzitolios A. The controversial role of B-vitamins in cardiovascular risk: an update. Arch Cardiovascular Dis 2009, 102:847-854.
81. 6-magnesium treatment in autism spectrum disorder. Cochrane Database Syst Rev 2005, CD003497.
82. Oulhaj A., Refsum H., Beaumont H., Williams J., King E., Jacoby R., Smith A.D. Homocysteine as a predictor of cognitive decline in Alzheimer's disease. Int J Geriatr Psychiat 2010, 25:182-190.
83. Passeri M., Cucinotta D., Abate G., Senin U., Ventura A., Stramba B.M., et al. Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. Aging 1993, 5:63-71.
84. Pathansali R., Mangoni A.A., Creagh-Brown B., Lan Z.C., Ngow G.L., Yuan X.F., Ouldred E.L., Sherwood R.A., Swift C.G., Jackson S.H. Effects of folic acid supplementation on psychomotor performance and hemorheology in healthy elderly subjects. Arch Gerontol Geriatr 2006, 43:127-137.
85. Pavlik V.N., Doody R.S., Rountree S.D., Darby E.J. Vitamin E use is associated with improved survival in an Alzheimer's disease cohort. Dement Geriatr Cogn Disord 2009, 28:536-540.
86. 12 deficiency and depression in physically disabled older women: epidemiologic evidence from the women's health and aging study. Am J Psychiatry 2000, 157:715-721.
87. Perkins A.J., Hendrie H.C., Callahan C.M., Gao S., Unverzagt F.W., Xu Y., Hall K.S., Hui S.L. Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am J Epidemiol 1999, 150:37-44.
88. Petersen R.C., Thomas R.G., Grundman M., Bennett D., Doody R., Ferris S., Galasko D., Jin S., Kaye J., Levey A., Pfeiffer E., Sano M., Van Dyck C.H., Thal L.J. Vitamin E and donepezil for the treatment of mild cognitive impairment. New Eng J Med 2005, 352:2379-2388.
89. 6 and magnesium in the treatment of autism: A methodology review and summary of outcomes. J Autism Dev Disorders 1995, 25:481-493.
90. Phillips G.B., Victor M., Adams R.D., Davidson C.S. A study of the nutritional defect in Wernicke's syndrome. J Clin Invest 1952, 31:859-871.
91. Praticò D. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharmacol Sci 2008, 29:609-615.
92. Price J., Kerr R., Hicks M., Nixon P.F. The Wernicke-Korsakoff syndrome: a reappraisal in Queensland with special reference to prevention. Med J Aust 1987, 147:561-565.
93. Ramos M.I., Allen L.H., Mungas D.M., Jagust W.J., Haan M.N., Green R., Miller J.W. Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2005, 82:1346-1352.
94. Ravaglia G., Forti P., Maioli F., Martelli M., Servadei L., Brunetti N., Porcellini E., Licastro F. Homocystine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005, 82:636-643.
95. 12, folic acid, and the nervous system. Lancet Neurol 2006, 5:949-960.
96. Richards M., Sacker A. Lifetime antecedents of cognitive reserve. J Clin Exp Neuropsychol 2003, 25:614-624.
97. Rimland B. An orthomolecular study of psychotic children. Orthomol Psychiatry 1974, 3:371-377.
98. 6 on autistic children: a double-blind crossover study. Am J Psychiatry 1978, 135:472-475.
99. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. New Eng J Med 1997, 336:1216-1222.
100. Sechi G., Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 2007, 6:442-455.
101. Savage D.G., Lindenbaum J. Neurological complications of acquired cobala-min deficiency: clinical aspects. Baillieres Clin Haematol 1995, 8:657-678.
102. Schneider J.A., Rees D.C., Liu Y.T., Clegg J.B. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet 1998, 62:1258-1260.
103. 12 concentrations. J Am Geriatr Soc 2002, 50:146-151.
104. Selhub J., Savaria Morris M.S., Jacques P.F., Rosenberg I.H. Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency. Am J Clin Nutr 2009, 89:702S-706S.
105. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'agostino R.B., Peter W.F., Wilson P.W.F., Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New Eng J Med 2002, 346:476-483.
106. Shorvon S.D., Carney M.W.P., Chanarin I., Reynolds E.H. The neuropsychia-try of megaloblastic anaemia. Brit Med J 1980, 281:1036-1038.
107. Smidt L.J., Cremin F.M., Grivetti L.E., Clifford A.J. Influence of thiamin supplementation on the health and general well-being of an elderly Irish population with marginal thiamin deficiency. J Gerontol 1991, 46:M16-M22.
108. Smith A.D. Folic acid fortification: the good, the bad, and the puzzle of vitamin B-12. Am J Clin Nutr 2007, 85:3-5.
109. Smith A.D. The worldwide challenge of the dementias: a role for B vitamins and homocysteine?. Food Nutr Bull 2008, 29(2 Suppl ):S143-S172.
110. Smith A., Clark R., Nutt D., Haller J., Hayward S., Perry K. Anti-oxidant vitamins and mental performance of the elderly. Hum Psychopharm 1999, 14:459-471.
111. Srám R.J., Binková B., Topinka J., Kotesovec F., Fojtíková I., Hanel I., Klaschka J., Kocisóvá J., Prosek M., Machálek J. Effect of antioxidant supplementation in an elderly population. Basic Life Sci 1993, 61:459-477.
112. Stehouwer C.D.A., Van Guldener C. Homocysteine-lowering treatment: an overview. Expert Opin Pharmacother 2001, 2:1449-1460.
113. Subbarao K.V., Richardson J.S., Ang L.C. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem 1990, 55:342-345.
114. Sullivan E.V., Pfefferbaum A. Neuroimaging of the Wernicke-Korsakoff syndrome. Alcohol Alcohol 2009, 44:155-165.
115. Taylor M.J., Carney S.M., Goodwin G.M., Geddes J.R. Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol 2004, 18:251-256.
116. Tiemeier H., Van Tuijl H.R., Hofman A., Meijer J., Kiliaan A.J., Breteler M.M. Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry 2002, 159:2099-2101.
117. Tolmunen T., Hintikka J., Voutilainen S., Ruusunen A., Alfthan G., Nyyssönen K., Viinamäki H., Kaplan G.A., Salonen J.T. Association between depressive symptoms and serum concentrations of homocysteine in men: a population study. Am J Clin Nutr 2004, 80:1574-1578.
118. Tuttle W.W., Wilson M., Daum K., Rhodes H. Influence of various levels of thiamin intake on physiologic response. III. Reaction times. J Am Diet Assoc 1949, 25:21-22.
119. Van Uffelen J.G., Chin A., Paw M.J., Hopman-Rock M., Van Mechelen W. The effect of walking and vitamin B supplementation on quality of life in community-dwelling adults with mild cognitive impairment: a randomized, controlled trial. Qual Life Res 2007, 6:1137-1146.
120. Victor M., Adams R.D., Collins G.H. The Wernicke-Korsakoff syndrome: a clinical and pathological study of 245 patients, 82 with post-mortem examinations. Contemp Neurol Ser 1971, 7:1-206.
121. 12 status and rate of brain volume loss in community-dwelling elderly. Neurology 2008, 71:826-832.
122. Waraich P., Goldner E.M., Somers J.M., Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiat 2004, 49:124-138.
123. Wilder R.M. Symptoms and signs of thiamine deficiency. Res Pub Assoc Res Nervous Mental Dis 1943, 22:101-112.
124. 1) deficiency and the thiamine requirement of man. Further observations. Arch Int Med 1942, 69:721-738.
125. Williams E., Stewart-Knox B., Bradbury I., Rowland I., Pentieva K., Helander A., Mcnulty H. Effect of folic acid supplementation on mood and serotonin response in healthy males. Brit J Nutr 2005, 94:602-608.
126. Yaffe K., Clemons T.E., Mcbee W.L., Lindblad A.S. Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial. Neurology 2004, 63:1705-1707.
127. Zandi P.P., Anthony J.C., Khachaturian A.S., Stone S.V., Gustafson D., Tschanz J.T., Norton M.C., Welsh-Bohmer K.A., Breitner J.C. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 2004, 61:82-88.